# Esther Artime

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/esther-artime/

## Facts

| Field | Value |
| --- | --- |
| Citations | 532 |
| Field | Diabetes Management and Research |
| h-index | 10 |
| i10-index | 12 |
| Last Known Institution | University of Greater Manchester |
| OpenAlex ID | https://openalex.org/A5010583999 |
| ORCID iD | 0000-0003-4294-6462 |
| Works | 83 |

## Researcher papers

- [A comparison of organic and inorganic nitrates/nitrites](https://scholariq.org/papers/a-comparison-of-organic-and-inorganic-nitrates-nitrites/)
- [Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn’s disease) in Spain: A Systematic Review](https://scholariq.org/papers/epidemiological-clinical-patient-reported-and-economic-burden-of-inflammatory/)
- [A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post‐Authorization Studies](https://scholariq.org/papers/a-review-of-studies-evaluating-the-effectiveness-of-risk-minimisation-measures/)
- [Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review](https://scholariq.org/papers/epidemiology-and-economic-burden-of-cardiovascular-disease-in-patients-with-type/)
- [Are risk minimization measures for approved drugs in Europe effective? A systematic review](https://scholariq.org/papers/are-risk-minimization-measures-for-approved-drugs-in-europe-effective-a/)
- [A descriptive review of additional risk minimisation measures applied to EU centrally authorised medicines 2006-2015](https://scholariq.org/papers/a-descriptive-review-of-additional-risk-minimisation-measures-applied-to-eu/)
- [Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain](https://scholariq.org/papers/glucagon-like-peptide-1-receptor-agonists-in-type-2-diabetes-mellitus-data-from/)
- [The Impact of Patient Support Programs in Europe: A Systematic Literature Review](https://scholariq.org/papers/the-impact-of-patient-support-programs-in-europe-a-systematic-literature-review/)
- [Localised neuropathic pain in the primary care setting: a cross-sectional study of prevalence, clinical characteristics, treatment patterns, quality of life and sleep performance](https://scholariq.org/papers/localised-neuropathic-pain-in-the-primary-care-setting-a-cross-sectional-study/)
- [Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study](https://scholariq.org/papers/clinical-inertia-in-poorly-controlled-type-2-diabetes-mellitus-patients-with/)
- [\[Artículo traducido\] Características de los pacientes, patrones de tratamiento, uso de recursos y costes en adultos con dermatitis atópica moderada-grave en la práctica habitual en España: Estudio Derma-Atopic](https://scholariq.org/papers/articulo-traducido-caracteristicas-de-los-pacientes-patrones-de-tratamiento-uso/)

## Researcher topics

- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Obesity and Health Practices](https://scholariq.org/topics/obesity-and-health-practices/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [University of Greater Manchester](https://scholariq.org/institutions/university-of-greater-manchester/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.